[{"address1": "101 Lindenwood Drive", "address2": "Suite 225", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 875 3192", "website": "https://www.annovisbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. Annovis Bio, Inc. was incorporated in 2008 and is based in Malvern, Pennsylvania.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Dr. Maria L. Maccecchini Ph.D.", "age": 72, "title": "Founder, CEO, President & Executive Director", "yearBorn": 1951, "fiscalYear": 2022, "totalPay": 965600, "exercisedValue": 0, "unexercisedValue": 3749000}, {"maxAge": 1, "name": "Mr. Henry  Hagopian III, M.B.A.", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1968, "fiscalYear": 2022, "totalPay": 510049, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cheng  Fang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eve M. Damiano M.S., RAC", "title": "Senior Vice President of Regulatory Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Gaines", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 7.28, "open": 18.0, "dayLow": 5.3677, "dayHigh": 6.89, "regularMarketPreviousClose": 7.28, "regularMarketOpen": 18.0, "regularMarketDayLow": 5.3677, "regularMarketDayHigh": 6.89, "beta": 1.589, "forwardPE": -2.301653, "volume": 2153019, "regularMarketVolume": 2153019, "averageVolume": 426388, "averageVolume10days": 1490190, "averageDailyVolume10Day": 1490190, "bidSize": 1000, "askSize": 2200, "marketCap": 61389756, "fiftyTwoWeekLow": 5.23, "fiftyTwoWeekHigh": 22.49, "fiftyDayAverage": 10.441, "twoHundredDayAverage": 10.6254, "currency": "USD", "enterpriseValue": 55578216, "floatShares": 8142966, "sharesOutstanding": 11021500, "sharesShort": 1452712, "sharesShortPriorMonth": 1347838, "sharesShortPreviousMonthDate": 1710460800, "dateShortInterest": 1713139200, "sharesPercentSharesOut": 0.1319, "heldPercentInsiders": 0.24593, "heldPercentInstitutions": 0.11445, "shortRatio": 5.12, "shortPercentOfFloat": 0.174, "impliedSharesOutstanding": 11021500, "bookValue": -0.737, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -56204312, "trailingEps": -6.23, "forwardEps": -2.42, "52WeekChange": -0.6200546, "SandP52WeekChange": 0.23099434, "exchange": "NYQ", "quoteType": "EQUITY", "symbol": "ANVS", "underlyingSymbol": "ANVS", "shortName": "Annovis Bio, Inc.", "longName": "Annovis Bio, Inc.", "firstTradeDateEpochUtc": 1580308200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "e153bc75-9830-375d-bf5e-330db4df878a", "messageBoardId": "finmb_622711087", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.57, "targetHighPrice": 72.0, "targetLowPrice": 13.0, "targetMeanPrice": 33.4, "targetMedianPrice": 26.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 5754720, "totalCashPerShare": 0.523, "quickRatio": 1.345, "currentRatio": 2.386, "returnOnAssets": -1.21768, "returnOnEquity": -5.4639697, "freeCashflow": -23747072, "operatingCashflow": -39967304, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-01"}]